SK Fleck, J Baldauf, S Langner… - …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Cited by 1 - Related articles - All 7 versions
C Martins, A Rhoton Jr… - Neurosurgery, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ... All 3 versions
KD Heidenreich, GR Griffin, MB Lorenz… - Otology & …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Related articles - All 4 versions
A Abrari… - BMJ Case Reports, 2011 - casereports.bmj.com DESCRIPTION The manifestations of Langerhans cell histiocytosis (LCH) are legion in both local and systemic variants. About 15–61% patients with LCH have otologic involvement; this manifestation is more frequent in children with mul- tisystem disease and a primary ... Related articles - All 2 versions
MT Shu, HC Lin, JC Lee… - Otology & Neurotology, 2011 - journals.lww.com A 65-year-old man with a diagnosis of stage T2bN3aM0 NPC (Fig. 1) had been treated with concurrent chemoradiation therapy. The radiation dose was 8,070 cGy to the gross tumor in the nasopharynx. Left ear discharge was noted occasionally after concurrent chemoradiation ... Related articles - All 3 versions